Cargando…
Possible underreporting of pathogenic variants in RAI1 causing Smith–Magenis syndrome
Autores principales: | Boot, Erik, Linders, Cathelijne C., Tromp, Sterre H., van den Boogaard, Marie‐José, van Eeghen, Agnies M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519085/ https://www.ncbi.nlm.nih.gov/pubmed/34089220 http://dx.doi.org/10.1002/ajmg.a.62380 |
Ejemplares similares
-
Intellectual and Behavioral Phenotypes of Smith–Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant
por: Linders, Cathelijne C., et al.
Publicado: (2023) -
RAI1 gene mutations: mechanisms of Smith–Magenis syndrome
por: Falco, Mariateresa, et al.
Publicado: (2017) -
RAI1 Transcription Factor Activity Is Impaired in Mutants Associated with Smith-Magenis Syndrome
por: Carmona-Mora, Paulina, et al.
Publicado: (2012) -
Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials
por: Müller, A. R., et al.
Publicado: (2021) -
Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith–Magenis syndrome
por: Chang, Ya-Ting, et al.
Publicado: (2022)